« Accelerated Approval of Hiberix to Help Sustain Adequate Vaccine Supply | Main | Cervista? HPV 16/18 These reagents are used with the Invader »

Abbott Issues Voluntary Recall of POWERSAIL Coronary Dilatation Catheters Abbott


Abbott Issues Voluntary Recall of POWERSAIL Coronary Dilatation Catheters
Abbott has conducted a voluntary recall of three lots of POWERSAIL Coronary Dilatation Catheters from United States distribution and one lot from international distribution as a result of four complaints (one from each lot) that the distal shaft of the catheter exhibited damage. While the issue could be detected and avoided during the preparation for use of the product, it may cause a leak of contrast material during use, which could lead to catheter functional failures and clinical consequences, including air embolism and myocardial infarction, which has the potential to lead to death...

Barr Laboratories, Inc. issues a voluntary nationwide recall of Dextroamphetamine/Amphetamine 20mg Tablets, Lot number 311756
Barr Laboratories, Inc. is initiating a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single Entity Amphetamine Product) 20mg Tablets, 100 count bottles, lot number 311756. The product identified is being recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets...
 

©2006 FDA-News.com. All rights reserved.